The recent development in mass spectrometry technology allows for rapid identification of pathogens within mere minutes, a significant improvement over the traditional days-long methods. This could revolutionize diagnostic processes, particularly in healthcare settings. However, challenges related to costs and the need for high-resolution equipment remain concerning. High-end mass spectrometers are particularly expensive, limiting access for smaller facilities which may find the alternatives, like bacterial cultures, to be more economically feasible. The discussion raises questions about the scalability of this technology in routine diagnostics. Some commenters noted alternatives such as multi-spectral imaging which can detect issues early and may be more accessible for smaller operations.